Atorvastatin calcium

- CAS No.
- 134523-03-8
- Chemical Name:
- Atorvastatin calcium
- Synonyms
- Atorvastatin CalciuM Trihydrate;ATORVASTATIN CA;Atrovastatin calcium;ATORVASTATIN CALCIUM SALT;Atorvastatin Ca Hydrate;Atorvastatin Calcium RS;Atorvastatin Calcium Anhydrous;Atorvastatin calciuM salt trihydrate;[r-(r*, r*)]-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1h-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt;Tahor
- CBNumber:
- CB4260130
- Molecular Formula:
- C33H37CaFN2O5
- Molecular Weight:
- 600.74
- MOL File:
- 134523-03-8.mol
- MSDS File:
- SDS
- Modify Date:
- 2025/4/21 13:17:25
Melting point | 176-178°C |
---|---|
storage temp. | Keep in dark place,Inert atmosphere,2-8°C |
solubility | DMSO: ≥10mg/mL |
form | white powder |
color | White to Off-White |
BCS Class | 2 |
InChIKey | FQCKMBLVYCEXJB-MNSAWQCASA-L |
SMILES | C(C1=C(N(CC[C@@H](O)C[C@@H](O)CC(=O)O)C(C2C=CC(F)=CC=2)=C1C1C=CC=CC=1)C(C)C)(=O)NC1C=CC=CC=1.[Ca] |&1:6,9,r| |
CAS DataBase Reference | 134523-03-8(CAS DataBase Reference) |
EPA Substance Registry System | 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-.beta.,delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1),(.beta.R,.delta.R)- (134523-03-8) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() ![]() ![]() GHS07,GHS08,GHS09 |
---|---|
Signal word | Warning |
Hazard statements | H411-H351-H361f-H372-H319 |
Precautionary statements | P201-P202-P281-P308+P313-P405-P501-P260-P264-P270-P314-P501-P264-P280-P305+P351+P338-P337+P313P |
Hazard Codes | Xn,T,F |
Risk Statements | 20/21/22-36/37/38-39/23/24/25-23/24/25-11 |
Safety Statements | 26-36-45-36/37-16-7 |
WGK Germany | 3 |
Atorvastatin calcium Chemical Properties,Uses,Production
Description
Lipitor was launched in Canada, the Netherlands, the UK and the US as an orally-active hypocholesterolemic agent. It was the first pharmaceutical product ever to attain over one billion dollars in sales in its first year. It can be synthesized by a number of routes but the most efficient involves the Paal-Knorr reaction of an acetonide protected dihydroxy amino ester and a diaryl phenylacetamide diketone. Lipitor is a liver selective, reversible competitive inhibitor of HMG-CoA reductase, the rate limiting step in cholesterol biosynthesis. Lipitor monotherapy resulted in a reduction of LDL cholesterol by up to 60%. Lipitor is about 2-4 times more potent, on a dosage basis, than Simvastatin. The superior properties of Lipitor can be attributed to its greater uptake and longer duration of action in the liver. In addition to its effects on cholesterol, Lipitor is also effective in lowering triglycerides. While the mechanism is not clear, two theories proposed are: a) the decrease in cholesterol causes a concomitant increase in hepatic LDL-receptor activity (mostly B and E type) which results in a decrease in triglycerides through an increase in binding of triglycerides to VLDL and LDL, and b) the decreased level of cholesterol impairs VLDL transport of triglycerides.
Chemical Properties
White Crystalline Powder
Uses
A selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia
Definition
ChEBI: An organic calcium salt composed of calcium cations and atorvastatin anions in a 1:2 ratio.
Biological Activity
Potent HMG-CoA reductase inhibitor (IC 50 = 8 nM). Reduces circulating LDL-C by inhibiting cholesterol biosynthesis and inducing expression of LDL receptors. Inhibits smooth muscle cell proliferation in vitro and exhibits antinociceptive effects in the inflammatory hypernociception model.
Atorvastatin calcium Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Jigs Chemical ltd | +919099003427 | Gujarat, India | 239 | 58 | Inquiry |
Cadila Pharmaceuticals Ltd | +91-7069076657 +91-7069076657 | Ahmedabad, India | 53 | 58 | Inquiry |
ANWITA APIS | +919000311012 | Hyderabad, India | 195 | 58 | Inquiry |
Apotex Pharmachem India Pvt Ltd | +91-8022891034 +91-8022891000 | Karnataka, India | 109 | 58 | Inquiry |
Chemeca Drugs Private Limited (Vegesna Laboratories Pvt Ltd) | +91-8924236065 +91-9951616502 | AndhraPradesh, India | 48 | 58 | Inquiry |
Anuh Pharma Ltd (SK GROUP) | +912266227575 | Maharashtra, India | 38 | 58 | Inquiry |
Hetero Drugs Limited | +91-4023704923 +91-4023704923 | Telangana, India | 296 | 58 | Inquiry |
Mankind Pharma Limited | +91-1146541111 +91-1146541111 | New Delhi, India | 23 | 58 | Inquiry |
Macleods Pharmaceuticals Limited | +91-2266762800 +91-2266762800 | Maharashtra, India | 116 | 58 | Inquiry |
Sun Pharmaceutical Industries Ltd | +91-2242244224 +91-2243244324 | Maharashtra, India | 108 | 58 | Inquiry |
Related articles
- Atorvastatin calcium: Chemical property, Spectroscopy, and Side effects
- Atorvastatin calcium (LIPITOR ) is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that conv....
- Sep 2,2024
134523-03-8(Atorvastatin calcium)Related Search:
1of4
chevron_right